Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
Patents for C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
12/2010
12/08/2010CN101531656B Lamivudine crystal form and preparation method thereof
12/07/2010US7846945 2-[4-Chloro-3-(4-hydroxy-benzyl)-phenyl]-6-methoxy-tetrahydro-pyran-3,4,5-triol; 2-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-3,4,5-trihydroxy-piperidine-1-carboxylic acid methyl ester; (2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-methoxytetrahydro-2H-thiopyran-3,4,5-triol; antidibetic, antiobesity agents
12/02/2010US20100301314 Conjugated compound, nitrogenated condensed-ring compound, nitrogenated condensed-ring polymer, organic thin film, and organic thin film element
12/01/2010CN101903353A Aminopyrazole derivatives
11/2010
11/30/2010CA2513440C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
11/25/2010WO2010067375A3 Optical resolution of substituted 1.3-oxathiolane nucleosides
11/25/2010WO2010056585A3 Heteroaryl diamide compounds useful as mmp-13 inhibitors
11/25/2010US20100298253 Pharmaceutical Compositions Comprising Forms of 5-Azacytidine
11/23/2010US7836898 Reduced tendency of cigarretes to ignite fire-prone substrates by using a permeability reducing substance, a burn rate retardant and a burn rate accelerant that also act as an organoleptic enhancers
11/23/2010CA2563022C Process for preparing 1,3-dioxolane derivatives
11/16/2010US7834194 Metabolic disorders; antidiabetic agents; hypoglycemic agents; obesity; hypotensive agents
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010CA2427548C Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/03/2010EP2245008A1 Method for the preparation of atorvastatin and intermediates used therein
10/2010
10/28/2010WO2009118765A3 Novel monoamine re-uptake inhibitor
10/27/2010EP2242743A1 Aminopyrazole derivatives
10/21/2010US20100267754 Integrin expression inhibitor
10/20/2010EP2007758B1 A novel crystalline form of lamivudine
10/19/2010US7816393 phosphodiesterase 4 inhibitors such as 4-Carbamoyl-4-{4-[(furan-2-yl-methylamino]-1,3-dioxo 1,3-dihydro-isoindol-2-yl}-butyric acid for treatment of cancer; immunotherapy
10/07/2010US20100256372 Process for producing 5-fluoro-1-(2r, 5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
10/05/2010CA2400479C Platelet adp receptor inhibitors
10/05/2010CA2352679C Process for the preparation of 3-aryl-benzofuran-2-ones
09/2010
09/28/2010US7803798 useful in treating vision defects, inflammatory bowel disease, alopecia, the stimulation of hair growth and the stimulation of the conversion of vellus hair to terminal hair
09/28/2010CA2395772C Sulfonamide-containing heterocyclic compounds
09/23/2010WO2010107487A2 Lipid-drug conjugates for drug delivery
09/23/2010US20100240883 Lipid-drug conjugates for drug delivery
09/21/2010US7799915 Several exemplified (pyrimidin-2-ylamino)benzenesulfonamide compounds such as N-phenyl-4-[(4-thien-2-ylpyrimidin-2-yl)amino]benzenesulfonamide; I kappa B kinase inhibitors (IKK inhibitors); anticancer agents, autoimmune diseases, osteoporosis
09/16/2010WO2010104314A2 Method for preparing non-crystalline (+)-lansoprazole and (+)-lansoprazole alcoholate used in same
09/15/2010EP2227478A1 Process and intermediates for the preparation of substituted 1, 3-oxathiolanes, especially lamivudine
09/15/2010EP2227465A1 Crystalline form i of lamivudine and its preparation
09/15/2010EP1501819B1 Estrogen receptor modulators
09/15/2010CN101830893A Synthesis and preparation process of lamivudine intermediate HDMS
09/10/2010WO2009118765A8 Novel monoamine re-uptake inhibitor
09/08/2010EP2225232A1 Process for the preparation of substituted 1,3-oxathiolanes
09/07/2010US7790887 (8E,12E,14E)-7-{(4-cycloheptylpiperazin-1-yl)carbonyl}oxy-3,6,16,21-tetrahydroxy-6,10,12,16,20-pentamethyl-18,19-epoxytricosa-8,12,14-trien-11-olide; carbonylating the protected 7-hydroxymacrolide; reacting with 1-cycloheptylpiperazine; desilylation, detherification; high purity, uniformity, workability
09/02/2010WO2010053861A3 Biologically active amides
08/2010
08/31/2010US7786141 Treating neurodegenerative diseases, psychological disorders, pain, glaucoma, dru eye, dry mouth, Sjogren's syndrome, asthma, bradycardia, wound healing, gastrointestinal disorders; amide- or urea-functional C5.C5N.C6 SPIRO(INDENE-2,4'-PIPERIDINE) RING structures; selective as to subtypes M1-M5
08/31/2010CA2364493C Nitrate esters and their use for neurological conditions
08/26/2010US20100216833 Tetrahydrocarbazoles and derivatives
08/24/2010US7781592 Thione derivative, method for the preparation thereof, and pharmaceutical composition containing the same
08/24/2010US7781456 The desired characteristics of chiral compounds helps reduce the toxicity of compound; to treat mood disorders, depression; pain, neurodegenerative disorders, sexual disorders, drug abuse etc.
08/24/2010US7781431 Thienopyrroles as antiviral agents
08/24/2010CA2460135C Use of pyridazinone compounds as phosphodiesterase iv inhibitors for treating cancer and other diseases
08/19/2010US20100210696 5-membered heterocyclic compound
08/18/2010CN101805335A Lamivudine compound and novel preparation method thereof
08/18/2010CN101805334A Lamivudin stearate and synthesis method and application
08/17/2010US7776876 administering cyclic Glycyl-2-Allyl Proline as as neuroprotectants, for the prophylaxis of nervous system disorders
08/12/2010US20100204200 Inhibitors of cathepsin s
08/10/2010US7772199 Forms of 5-azacytidine
08/03/2010US7767812 Crystals of pyrimidine compound and process for producing the same
07/2010
07/27/2010US7763608 Factor Xa inhibitors
07/22/2010WO2010082128A1 Process for the preparation of cis-nucleoside derivative
07/20/2010CA2399001C Integrin expression inhibitor
07/13/2010US7754746 3-{3-[5-(4-acetylphenyl)-4-methylthiazol-2-yl]-ureido}-N-tert-butylpropionamide, exhibiting phosphatidylinositol 3-kinase inhibitory activity and used for treating respiratory system disorders, such as asthma
07/13/2010US7754741 nonphytotoxic of N-[2-(3-Chloro-5-trifluoromethyl-pyridin-2-yl) ethyl]-2-trifluoromethyl-nicotinamide, used for controlling phytopathogenic fungi selected from Alternaria and Pyrenophora
07/13/2010US7754727 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents
07/13/2010US7754723 Therapeutic agents useful for treating pain
07/06/2010USRE41425 Piperazine and piperidine compounds
07/01/2010US20100168156 Novel Benzoxathiine Derivative
06/2010
06/30/2010EP2201004A1 Novel benzooxazol- and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
06/30/2010CN101765589A fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives
06/29/2010US7745453 Hydroxypyrimidinone derivatives having inhibitory activity against HIV integrase
06/29/2010US7745442 Methods of reducing risk of infection from pathogens
06/24/2010WO2010069877A1 Isothiazole and pyrazole derivatives for use as plant growth regulators
06/17/2010WO2010067375A2 Optical resolution of substituted 1.3-oxathiolane nucleosides
06/16/2010CN101743237A condensed anthranilamide insecticides
06/15/2010US7737275 simple and low cost chemical process of 2-chloro-5-[3,6-dihydro-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide
06/15/2010US7737269 Process for preparing an alpha-lipoic acid/cyclodextrin complex and product prepared
06/15/2010US7737153 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
06/08/2010US7732449 preferential enzyme Inhibitors such as 4-(4-Acetyl-piperazin-1-yl)-2-(R)-cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-butyramide, used for the treatment of inflammation, arthritis and atherosclerosis
06/02/2010EP2190839A1 A process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes
06/02/2010EP2001478B1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
05/2010
05/27/2010WO2010058060A1 Aryl piperazine and their use as alpha2c antagonists
05/27/2010CA2741986A1 Method and apparatus for manure treatment
05/20/2010WO2010055526A1 A novel polymorph of emtricitabine and a process for preparing of the same
05/20/2010CA2743146A1 Heteroaryl diamide compounds useful as mmp-13 inhibitors
05/19/2010EP2185526A2 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives
05/19/2010EP1485380B1 Azolylaminoazines as inhibitors of protein kinases
05/14/2010WO2010053861A2 Biologically active amides
05/04/2010CA2439001C Water-soluble triazole antifungal agents
04/2010
04/27/2010US7704995 Protein kinase modulators and methods of use
04/21/2010EP1258252B1 Integrin expression inhibitors
04/21/2010CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors
04/14/2010EP2174939A1 Pyranones useful as ATM inhibitors
03/2010
03/31/2010EP2167485A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
03/31/2010EP2167484A2 Condensed anthranilamide insecticides
03/30/2010US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders
03/30/2010US7687067 combating phytopathogenic fungi
03/30/2010CA2375075C Methods of separating ftc isomers and derivatives thereof
03/23/2010US7683078 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide
03/17/2010CN101671333A Method for separating emtricitabine
03/17/2010CN101671332A Method for chiral preparation of lamivudine
03/16/2010US7678918 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
03/16/2010US7678904 or to treat autoimmune and inflammatory disorders; improved water solubility characteristics
03/16/2010US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
03/16/2010US7678790 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents
03/11/2010WO2010025850A1 Heterocyclically substituted anilinopyrimidines as fungicides
03/11/2010US20100063045 Novel pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 25